Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01683422 · ClinicalTrials.gov registry record · NA
Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01683422: Clinical Trial NA study, sponsored by Loma Linda University.
NCT01683422 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01683422, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The current trial will provide important data on the recurrence rates and patterns of failure using state of the art target agent, chemotherapy and proton beam technology for patients with Locally Advanced Pancreatic Cancer (LAPC). A median survival of 10 months or greater would be considered evidence of a regimen potentially worthy of further study as a new treatment paradigm in one arm in a future phase III trial.
Primary Outcome
Subjects will be followed after treatment completed to determine length of survival rate. The primary study objective was 1-year overall survival (OS, failure: death due to any cause). The Kaplan-Meier method was used to estimate the one-year OS. Secondary Objectives were the frequency of serious adverse events, disease control rate and progression-free survival.
Interventions
- RADIATION Proton Radiation
- RADIATION Proton, Gemcitabine, Erlotinib, Capecitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-01-02 |
| Est. Completion | 2019-02-19 |
| Phase | NA |
Why NCT01683422 stopped before completion
NCT01683422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Proton Radiation is the first listed.
NCT01683422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01683422 about?
NCT01683422 is a clinical study titled "Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer". The current trial will provide important data on the recurrence rates and patterns of failure using state of the art target agent, chemotherapy and proton beam technology for patients with Locally Advanced Pancreatic Cancer (LAPC). A median survival of 10 months or greater would be considered eviden...
What is the current status of trial NCT01683422?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2013-01-02. Estimated completion is 2019-02-19.
What interventions are being tested in trial NCT01683422?
The interventions under investigation include: Proton Radiation (RADIATION), Proton, Gemcitabine, Erlotinib, Capecitabine (RADIATION).
Who is sponsoring clinical trial NCT01683422?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01683422's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI